Skip to main content
SpringerLink
Log in

Comorbidity Index

  • Chapter
  • First Online:
Comorbidity in Rheumatic Diseases

Abstract

The impact of comorbidity on the outcomes of interest in rheumatic diseases is noteworthy: comorbidity has proven to be a more significant predictor of premature death than shared epitope, rheumatoid factor, or erosions in inflammatory arthritis. Therefore, controlling for coexisting clinical conditions, or comorbidities, booked its place as a main confounder, both in standard healthcare practice and in research. Comorbidity indices are tools used to quantify the total burden of comorbidity contributing to the patient’s overall illness. The simplest method to measure comorbidity is to use the summation of each comorbid illness to generate a total value of comorbidity, often termed a “comorbidity count.” However, not all comorbid diseases have the same impact on the outcome of interest. Thus, more complex comorbidity indices were created to select and weight specific comorbid illnesses to measure more accurately the burden and impact of overall comorbidity. Comorbidities can also be categorized based on the way they have been recorded, whether by administrative data, e.g., the International Classification of Diseases, or by self-administered questionnaires. With the substantial impact that comorbidity exerts on health outcomes in patients with rheumatic diseases, and given the lack of a standardized comorbidity index for clinical or research use, there is an obvious need for an accurate tool to measure the burden of comorbidity in patients with rheumatic disease. This chapter discusses the most commonly used instruments, as well as the recently developed comorbidity indices, their implication onto standard rheumatology clinical practice as well as on patients’ management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481–94.

    Article  CAS  PubMed  Google Scholar 

  2. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11:229.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Gabriel SE. Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis. 2008;67:30–4.

    Article  Google Scholar 

  4. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455–68.

    Article  CAS  PubMed  Google Scholar 

  5. Avina-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690–7.

    Article  PubMed  Google Scholar 

  6. Lindhardsen J, Ahlehoff O, Gislason GH, et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis. 2011;70:929–34.

    Article  PubMed  Google Scholar 

  7. Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford). 2013;52:53–61.

    Article  CAS  Google Scholar 

  8. Wotton CJ, Goldacre MJ. Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses. J Epidemiol Community Health. 2012;66:1177–81.

    Article  PubMed  Google Scholar 

  9. Uresson C, Matteson EL. Malignancy as a comorbidity in rheumatic diseases. Rheumatology (Oxford). 2013;52:5–14.

    Article  Google Scholar 

  10. England B, Sayles H, Mikuls TED, Johnson D, Michaud A. Validation of the rheumatic disease comorbidity index. Arthritis Care Res. 2015;67(6):865–72.

    Article  Google Scholar 

  11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

    Article  CAS  PubMed  Google Scholar 

  12. Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol. 2005;58:595–602.

    Article  PubMed  Google Scholar 

  13. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis. 1974;27:387–404.

    Article  CAS  PubMed  Google Scholar 

  14. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the cumulative illness rating scale. Psychiatry Res. 1992;41:237–48.

    Article  CAS  PubMed  Google Scholar 

  15. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197–203.

    Google Scholar 

  16. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.

    Article  CAS  PubMed  Google Scholar 

  17. Hall SF. A user’s guide to selecting a comorbidity index for clinical research. J Clin Epidemiol. 2006;59:849–55.

    Article  PubMed  Google Scholar 

  18. Kiefe CI, Funkhouser E, Fouad MN, May DS. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med. 1998;13:357–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use, vol. 2. Oxford: Oxford University Press; 1995. p. 1–230.

    Google Scholar 

  20. Rochon PA, Katz JN, Morrow LA, et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. Med Care. 1996;34:1093–101.

    Article  CAS  PubMed  Google Scholar 

  21. Gabriel SE, Crowson CS, O’Fallon WM. A comparison of two comorbidity instruments in arthritis. J Clin Epidemiol. 1999;52:1137–42.

    Article  CAS  PubMed  Google Scholar 

  22. Kieszak SM, Flanders WD, Kosinski AS, Shipp CC, Karp H. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol. 1999;52:137–42.

    Article  CAS  PubMed  Google Scholar 

  23. Poses RM, McClish DK, Smith WR, Bekes C, Scott WE. Prediction of survival of critically ill patients by admission comorbidity. J Clin Epidemiol. 1996;49:743–7.

    Article  CAS  PubMed  Google Scholar 

  24. Fletcher RH, Fletcher SW, WAGNER EH. Clinical epidemiology: the essentials. 3rd ed. Baltimore: Williams & Wilkins; 1996.

    Google Scholar 

  25. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56:221–9.

    Article  PubMed  Google Scholar 

  26. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be assessed by questionnaire rather than medical record review ? Med Care. 1996;34:73–84.

    Article  CAS  PubMed  Google Scholar 

  27. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.

    Article  CAS  PubMed  Google Scholar 

  28. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075–9.

    Article  CAS  PubMed  Google Scholar 

  29. Halfon P, Eggli Y, van Melle G, Chevalier J, Wasserfallen JB, Burnand B. Measuring potentially avoidable hospital readmissions. J Clin Epidemiol. 2002;55(6):573–87.

    Article  PubMed  Google Scholar 

  30. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.

    Article  PubMed  Google Scholar 

  31. Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003;38(4):1103–20.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Sarfati D, Tan L, Blakely T, et al. Comorbidity among patients with colon cancer in New Zealand. N Z Med J. 2011;124(1338):76–88.

    PubMed  Google Scholar 

  33. Mnatzaganian G, Ryan P, Norman PE, et al. Accuracy of hospital morbidity data and the performance of comorbidity scores as predictors of mortality. J Clin Epidemiol. 2012;65(1):107–15.

    Article  PubMed  Google Scholar 

  34. Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care. 2005;20(1):12–9.

    Article  PubMed  Google Scholar 

  35. Moltó A, Dougados M. Comorbidity indices. Clin Exp Rheumatol. 2014;32(Suppl. 85):S131–4.

    Google Scholar 

  36. Condon JR, You J, McDonnell J. Performance of comorbidity indices in measuring outcomes after acute myocardial infarction in Australian indigenous and non-indigenous patients. Intern Med J. 2012;42:e165–73.

    Article  CAS  PubMed  Google Scholar 

  37. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care. 2004;42:355–60.

    Article  PubMed  Google Scholar 

  38. Menendez ME, Neuhaus V, van Dijk CN, Ring D. The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery. Clin Orthop Relat Res. 2014;472:2878–86.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Dominick KL, Dudley TK, Coffman CJ, Bosworth HB. Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum. 2005;53:666–72.

    Article  PubMed  Google Scholar 

  40. Antoniou T, Ng R, Glazier RH, Kopp A, Austin PC. Comparison of comorbidity classification methods for predicting outcomes in a population-based cohort of adults with human immunodeficiency virus infection. Ann Epidemiol. 2014;24:532–7.

    Article  PubMed  Google Scholar 

  41. Gandjour A, Ku-Goto MH, Ho V. Comparing the validity of different measures of illness severity: a hospital-level analysis for acute myocardial infarction. Health Serv Manag Res. 2012;25:138–43.

    Article  Google Scholar 

  42. Sharabiani M, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50(12):1109–18.

    Article  PubMed  Google Scholar 

  43. Garland A, Fransoo R, Olafson K, Ramsey C, Yogendran M, Chateau D, McGowan K. The epidemiology and outcomes of critical illness in Manitoba. Winnipeg: Manitoba Centre for Health Policy; 2012.

    Google Scholar 

  44. Van Walraven C, Austin PC, Jenings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626–33.

    Article  PubMed  Google Scholar 

  45. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16:622–6.

    Article  CAS  PubMed  Google Scholar 

  46. Extermann M, Overcash J, Lyman G, Parr J, Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16(4):1582–7.

    Article  CAS  PubMed  Google Scholar 

  47. Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, Parodi S, Dal Lago D, Gioia F, Monfardini S, Aapro MS, Serraino D, Zagonel V. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20(2):494–502.

    Article  PubMed  Google Scholar 

  48. Grolla D, Tob T, Bombardierc C, Wrightd J. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol. 2005;58:595–602.

    Article  Google Scholar 

  49. Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21:885–906.

    Article  PubMed  Google Scholar 

  50. Chang TI, Paik J, Greene T, Miskulin DC, Chertow GM. Updated comorbidity assessments and outcomes in prevalent hemodialysis patients. Hemodial Int. 2010;14:478–85.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Rander H, Yoshida K, Mjaavatten M, Aletaha D, et al. Development of a multimorbidity index: impact on quality of life using a rheumatoid arthritis cohort. Semin Arth Rheumatsim. 2015;45(2):167–73.

    Article  Google Scholar 

  52. Radner H, Smolen JS, Aletaha D. Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology (Oxford). 2010;50:381–8.

    Article  Google Scholar 

  53. Frenkel WJ, Jongerius EJ, Mandjes-van Uitert MJ, van Munster BC, de Rooij SE. Validation of the Charlson comorbidity index in acutely hospitalized elderly adults: a prospective cohort study. J Am Geriatr Soc. 2014;62:342–6.

    Article  PubMed  Google Scholar 

  54. Sangha O, Stucki G, Liang M, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49:156–63.

    Article  PubMed  Google Scholar 

  55. Stolwijk C, van Tubergen A, Ramiro S, et al. Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis. Rheumatology (Oxford). 2014;53:1054–64.

    Article  Google Scholar 

  56. El Miedany Y. Co-morbidity index in rheumatoid arthritis: time to think. Clin Rheumatol. 2015;34(12):1995–2000.

    Article  PubMed  Google Scholar 

  57. El Miedany Y, El Gaafary M, Youssef S, Bahlas S, Ahmed I, Hegazi M. Rheumatoid arthritis comorbidity index: development and validation of a new specific tool for classifying prognostic comorbidity in rheumatoid arthritis patients. Ann Rheum Dis. 2016;75(Suppl2):154.

    Google Scholar 

  58. El Miedany Y, El Gaafary M, Youssef S, Bahlas S, Hegazi M. Psoriatic arthritis comorbidity index: development and validation of a new specific tool for classifying prognostic comorbidity in psoriasis and psoriatic arthritis patients. Rheumatol Orthop Med. 2017;2 doi: 10.15761/ROM.1000117.

  59. NICEguidelines [CG79]. Rheumatoidarthritis:the management of rheumatoid arthritis in adults. http://www.nice.org.uk/guidance/cg79. 2009.

  60. Smolen J, Landewé R, Breedveld F, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73(3):492–509. doi:10.1136/annrheumdis-2013204573.

  61. Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2013;1:1–7. doi:10.1136/annrheumdis2013-204223.

    Google Scholar 

  62. Jacobsson LT, Knowler WC, Pillemer S, et al. Rheumatoid arthritis and mortality. A longitudinal study in pima Indians. Arthritis Rheum. 1993;36:1045–53.

    Article  CAS  PubMed  Google Scholar 

  63. Turesson C, McClelland RL, Christianson TJ, et al. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2007;66:70–5.

    Article  CAS  PubMed  Google Scholar 

  64. Nicola PJ, Maradit-Kremers H, Roger VL, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 2005;52:412–20.

    Article  PubMed  Google Scholar 

  65. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003;48:54–8.

    Article  PubMed  Google Scholar 

  66. Weinblatt ME, Coblyn JS, Fox DA, et al. Efficacy of lowdose methotrexate in rheumatoid arthritis. N Engl J Med. 1985;312:818–22.

    Article  CAS  PubMed  Google Scholar 

  67. Radner H, Yoshida K, Smolen J, Solomon D. Multimorbidity and rheumatic conditions—enhancing the concept of comorbidity. Nat Rev Rheumatol. 2014;10:252–6.

    Article  PubMed  Google Scholar 

  68. Miskulin DC, Athienites NV, Yan G, Martin AA, Ornt DB, et al. Comorbidity assessment using the index of coexistent diseases in a multicenter clinical trial. Kidney Int. 2001;60(4):1498–510.

    Article  CAS  PubMed  Google Scholar 

  69. Lieffers JR, Baracos VE, Winget M, Fassbender K. A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer. 2011;117:1957–65.

    Article  PubMed  Google Scholar 

  70. Baillet A, Gossec L, Carmona L, de Wit M, et al. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis. 2014;73(3):492–509. doi:10.1136/annrheumdis-2016-209233.

Download references

Acknowledgment

Special thanks to Dr. Loreto Carmona, MD, PhD, Research Director, Instituto de Salud Musculoesquelética, Madrid, Spain, for peer reviewing this chapter.

Author information

Authors and Affiliations

  1. King’s College, London, UK

    Yasser El Miedany

  2. Rheumatology and Rehabilitation, Ain Shams University, Cairo, Egypt

    Yasser El Miedany

  3. Department of Rheumatology, Darent Valley Hospital, Dartford, Kent, UK

    Yasser El Miedany

Authors
  1. Yasser El Miedany
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasser El Miedany .

Editor information

Editors and Affiliations

  1. Consultant Rheumatologist, Department of Rheumatology, Darent Valley Hospital, Dartford, Kent, United Kingdom

    Yasser El Miedany

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

El Miedany, Y. (2017). Comorbidity Index. In: El Miedany, Y. (eds) Comorbidity in Rheumatic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-59963-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59963-2_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59962-5

  • Online ISBN: 978-3-319-59963-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation